MedPath

VULINTUS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Evaluating the Efficacy of Opti-Speech for Speech Treatment

Not Applicable
Completed
Conditions
Dysarthria
Articulation Disorder
Prelingual Deafness
Interventions
Device: Opti-Speech
First Posted Date
2016-03-10
Last Posted Date
2018-12-31
Lead Sponsor
Vulintus, Inc.
Target Recruit Count
37
Registration Number
NCT02705326
Locations
🇺🇸

The Cleveland Hearing and Speech Center, Cleveland, Ohio, United States

🇺🇸

Callier Center for Communication Disorders at UT Dallas, Richardson, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath